Skip to content

Comparative Effects of Carnivore and Mediterranean-style Diets on LDL Aggregation and Cardiometabolic Health

Comparative Effects of Carnivore and Mediterranean-style Diets on LDL Aggregation Susceptibility and Cardiometabolic Health

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07462871
Acronym
MEDIVORE
Enrollment
30
Registered
2026-03-10
Start date
2026-06-01
Completion date
2027-06-01
Last updated
2026-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis Cardiovascular Disease, Dyslipidaemia, Metabolic Syndrome

Keywords

Atherosclerosis, ASCVD, Diet, carbohydrate-restricted, Ketogenic diet, LDL aggregation, Low-density lipoproteins, Lipoproteins, Lipid metabolism

Brief summary

The goal of this clinical trial is to learn whether following a Mediterranean-style diet or a Carnivore-style diet can improve heart and metabolic health in men and women aged 30-60 years with high LDL cholesterol. The main questions it aims to answer are: 1. Does following a Mediterranean or Carnivore diet change how easily LDL cholesterol particles clump together (LDL aggregation susceptibility)? 2. Do these two diets have different effects on other measures of heart and metabolic health, such as blood fats, blood vessel function, and overall wellbeing? Researchers will compare people who follow the Mediterranean-style diet with those who follow the Carnivore-style diet to see which diet produces more beneficial changes in cholesterol and heart health markers. Participants will: * Attend three visits at Liverpool John Moores University for screening and data collection. * Be randomly assigned to follow either the Mediterranean or Carnivore diet for 3 weeks, matched for calories and protein. * Provide fasting blood, urine, and stool samples before and after the diet period. * Complete non-invasive cardiovascular tests to measure blood vessel and heart function. * Take part in a short interview and complete questionnaires about their experience of following the diet.

Interventions

DIETARY_SUPPLEMENTCarnivore Diet

The intervention diet will consist of isocaloric consumption of exclusively of animal-based products, including red meat, poultry, and limited amounts of dairy products for 3 weeks. The diet will exclude plant-based foods, such as fruits, vegetables, grains, legumes, nuts, and seeds to reflect a traditional Carnivore-style dietary pattern.

DIETARY_SUPPLEMENTMediterranean Diet

The intervention diet will consist of isocaloric consumption of foods typical of a traditional Mediterranean dietary pattern, including fruits, vegetables, whole grains, legumes, nuts, olive oil, and fish, for a period of 3 weeks. The diet will include moderate amounts of poultry and dairy products and limited amounts of red and processed meat, refined carbohydrates, and added sugars.

Sponsors

Liverpool John Moores University
Lead SponsorOTHER
Wihuri Research Institute
CollaboratorOTHER
University of Helsinki
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female * 30-60 years of age * Elevated LDL cholesterol (LDL \>3mmol/L and/or non-HDL cholesterol \> 4mmol/L) * Not following any specific diet for health reasons. * Not currently taking lipid-lowering medications or supplements that may interfere with LDL levels.

Exclusion criteria

* Pregnancy or breastfeeding. * Known food allergies or intolerances. * Previous history of disordered eating. * Currently taking cholesterol-lowering medication or supplements.

Design outcomes

Primary

MeasureTime frameDescription
LDL aggregation susceptibilityBaseline and 3 weeks.To measure changes in how easily LDL cholesterol particles 'clump' together in the blood vessels from baseline to post-intervention, assessed via plasma lipid and lipoprotein analysis.

Secondary

MeasureTime frameDescription
Plasma lipid and lipoprotein profileBaseline and 3 weeks.Changes in plasma levels of total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides will be determined via enzymatic analysis and measured in mmol/L.
Lipoprotein particle sizeBaseline and 3 weeks.Changes in lipoprotein particle size (diameter) will be measured via Nuclear Magnetic Resonance spectroscopy (NMR) and expressed in nanometers.

Countries

United Kingdom

Contacts

CONTACTMegan Wilson, BSc Nutrition
M.L.Wilson@ljmu.ac.uk+447362317430
CONTACTDr Richie Kirwan
R.P.Kirwan@ljmu.ac.uk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026